JANSSEN SCIENCES IRELAND UC
Patent Owner
Stats
- 164 US PATENTS IN FORCE
- 12 US APPLICATIONS PENDING
- Feb 20, 2018 most recent publication
Details
- 164 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,494 Total Citation Count
- Jul 13, 1994 Earliest Filing
- 24 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0044,218 Use of a HIV derived accessory protein for the reactivation of latent HIVApr 23, 15Feb 16, 17[A61K, C07K]
2016/0347,741 SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS BFeb 05, 15Dec 01, 16[A61K, C07D]
2016/0271,165 POLYLNOSINIC-POLYCYTIDYLIC ACID (POLY (I:C)) FORMULATIONS FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONSNov 05, 14Sep 22, 16[A61K]
2015/0266,890 SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS BAug 28, 13Sep 24, 15[A61K, C07D, C07C]
2014/0296,799 Degradable Removable Implant for the Sustained Release of An Active CompoundJun 10, 14Oct 02, 14[A61K, A61L]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9895349 N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis BApr 02, 14Feb 20, 18[A61K, C07D]
9890178 Azabenzimidazoles as respiratory syncytial virus antiviral agentsApr 22, 16Feb 13, 18[C07F, C07D]
9884818 Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis BMay 16, 14Feb 06, 18[A61K, C07D]
9884864 Antibacterial cyclopenta[C]pyrrole substituted 3,4-Dihydro-1H-[1,8]naphthyridinonesMar 09, 17Feb 06, 18[A61K, C07D]
9845321 1,3-dihydro-2H-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agentsJan 08, 16Dec 19, 17[C07D]
9790191 Substituted acylaminopyrimidines as inducers of alpha interferon productionOct 03, 13Oct 17, 17[C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0165,287 CRYSTAL FORM OF A NUCLEOSIDE INHIBITOR OF HCVAbandonedNov 28, 13Jun 15, 17[A61K, C07H]
2016/0168,124 SUBSTITUTED PYRIDINE-PIPERAZINYL ANALOGUES AS RSV ANTIVIRAL COMPOUNDSAbandonedJul 29, 14Jun 16, 16[C07D]
2015/0329,482 Preparation of 13-Cyclohexyl-3-Methoxy-6-[Methyl-(2-(2-[Methyl-(Sulphamoyl)-Amino]-Ethoxy}-Ethyl)-Carbamoyl]-7H-Indolo-{2,1-a]-[2]-Benzazepine-10-Carboxylic AcidAbandonedJul 28, 15Nov 19, 15[C07C]
2015/0274,653 SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS BAbandonedAug 28, 13Oct 01, 15[A61K, C07D, C07C]
2015/0175,608 NOVEL 4-SUBSTITUTED 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTSAbandonedJun 14, 13Jun 25, 15[C07D]
2015/0166,533 NOVEL 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTSAbandonedJun 14, 13Jun 18, 15[C07D]
2015/0158,862 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTSAbandonedJun 14, 13Jun 11, 15[C07D]
2015/0111,868 NOVEL 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTSAbandonedJun 14, 13Apr 23, 15[C07D]
2014/0349,971 Combinations of A Pyrimidine Containing NNRTI with RT InhibitorsAbandonedAug 07, 14Nov 27, 14[A61K]
2014/0171,499 Pseudopolymorphic Forms Of A HIV Protease InhibitorAbandonedFeb 19, 14Jun 19, 14[C07D]
8557854 Use of a sulfonamide compound for improving the pharmacokinetics of a drugExpiredApr 14, 06Oct 15, 13[A61K, C07D]
2012/0310,616 COMPUTATION OF THE COMBINED POTENCY OF DRUG REGIMENS FROM FITTED OR IN VITRO DETERMINED DOSE-RESPONSE CURVESAbandonedFeb 11, 11Dec 06, 12[G06G]
2012/0252,695 Predictive Value of IL28B Gene Polymorphism Combined with Pretreatment Serum IP-10 Quantification for Response to Peginterferon and Ribavirin Is Enhanced in Comparison with any of these Biomarkers aloneAbandonedDec 21, 10Oct 04, 12[C12Q, G01N, G06G, C40B]
2012/0220,520 BIOAVAILABLE COMBINATIONS FOR HCV TREATMENTAbandonedJan 26, 07Aug 30, 12[A61K, C07D, A61P]
2012/0201,868 TREATMENT AND PREVENTION OF HIV INFECTIONAbandonedSep 22, 10Aug 09, 12[A61K, B82Y, A61P]
2012/0058,920 Method for Identifying Inhibitors Against Dengue VirusAbandonedMay 11, 10Mar 08, 12[C12Q, C40B]
2011/0275,654 LONG TERM TREATMENT OF HIV-INFECTION WITH TMC278AbandonedJan 19, 07Nov 10, 11[A61K, A61P]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
